212 related articles for article (PubMed ID: 24868378)
1. X-linked dystonia parkinsonism: clinical phenotype, genetics and therapeutics.
Rosales RL
J Mov Disord; 2010 Oct; 3(2):32-8. PubMed ID: 24868378
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Phenotype and Genetics of X-Linked Dystonia-Parkinsonism (XDP; DYT3; Lubag).
Kawarai T; Morigaki R; Kaji R; Goto S
Brain Sci; 2017 Jun; 7(7):. PubMed ID: 28672841
[TBL] [Abstract][Full Text] [Related]
3. X-linked dystonia parkinsonism: epidemiology, genetics, clinical features, diagnosis, and treatment.
Chin HL; Lin CY; Chou OH
Acta Neurol Belg; 2023 Feb; 123(1):45-55. PubMed ID: 36418540
[TBL] [Abstract][Full Text] [Related]
4. Variation in TAF1 expression in female carrier induced pluripotent stem cells and human brain ontogeny has implications for adult neostriatum vulnerability in X-linked Dystonia Parkinsonism.
D'Ignazio L; Jacomini RS; Qamar B; Benjamin KJM; Arora R; Sawada T; Evans TA; Diffenderfer KE; Pankonin AR; Hendriks WT; Hyde TM; Kleinman JE; Weinberger DR; Bragg DC; Paquola ACM; Erwin JA
eNeuro; 2022 Jul; 9(4):. PubMed ID: 35868859
[TBL] [Abstract][Full Text] [Related]
5. Genetic study of an American family with DYT3 dystonia (lubag).
Deng H; Le WD; Jankovic J
Neurosci Lett; 2008 Dec; 448(2):180-3. PubMed ID: 18952144
[TBL] [Abstract][Full Text] [Related]
6. Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in
Bragg DC; Mangkalaphiban K; Vaine CA; Kulkarni NJ; Shin D; Yadav R; Dhakal J; Ton ML; Cheng A; Russo CT; Ang M; Acuña P; Go C; Franceour TN; Multhaupt-Buell T; Ito N; Müller U; Hendriks WT; Breakefield XO; Sharma N; Ozelius LJ
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E11020-E11028. PubMed ID: 29229810
[TBL] [Abstract][Full Text] [Related]
7. A scoping review on the diagnosis and treatment of X-linked dystonia-parkinsonism.
Alonto AHD; Jamora RDG
Parkinsonism Relat Disord; 2024 Feb; 119():105949. PubMed ID: 38072720
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Glucocorticoids on
Cruz SED; Bagamasbad P
J ASEAN Fed Endocr Soc; 2023; 38(1):23-30. PubMed ID: 37234925
[TBL] [Abstract][Full Text] [Related]
9. Bilateral pallidal deep brain stimulation for X-linked dystonia-parkinsonism.
Patel AJ; Sarwar AI; Jankovic J; Viswanathan A
World Neurosurg; 2014; 82(1-2):241.e1-4. PubMed ID: 24076056
[TBL] [Abstract][Full Text] [Related]
10. The natural history of sex-linked recessive dystonia parkinsonism of Panay, Philippines (XDP).
Lee LV; Maranon E; Demaisip C; Peralta O; Borres-Icasiano R; Arancillo J; Rivera C; Munoz E; Tan K; Reyes MT
Parkinsonism Relat Disord; 2002 Oct; 9(1):29-38. PubMed ID: 12217620
[TBL] [Abstract][Full Text] [Related]
11. The unique phenomenology of sex-linked dystonia parkinsonism (XDP, DYT3, "Lubag").
Lee LV; Rivera C; Teleg RA; Dantes MB; Pasco PM; Jamora RD; Arancillo J; Villareal-Jordan RF; Rosales RL; Demaisip C; Maranon E; Peralta O; Borres R; Tolentino C; Monding MJ; Sarcia S
Int J Neurosci; 2011; 121 Suppl 1():3-11. PubMed ID: 21047175
[TBL] [Abstract][Full Text] [Related]
12. Dissection of
Capponi S; Stöffler N; Penney EB; Grütz K; Nizamuddin S; Vermunt MW; Castelijns B; Fernandez-Cerado C; Legarda GP; Velasco-Andrada MS; Muñoz EL; Ang MA; Diesta CCE; Creyghton MP; Klein C; Bragg DC; De Rijk P; Timmers HTM
Brain Commun; 2021; 3(4):fcab253. PubMed ID: 34746789
[TBL] [Abstract][Full Text] [Related]
13. Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells.
Ito N; Hendriks WT; Dhakal J; Vaine CA; Liu C; Shin D; Shin K; Wakabayashi-Ito N; Dy M; Multhaupt-Buell T; Sharma N; Breakefield XO; Bragg DC
Dis Model Mech; 2016 Apr; 9(4):451-62. PubMed ID: 26769797
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and molecular analyses of X-linked dystonia-parkinsonism ("lubag") in women.
Evidente VG; Nolte D; Niemann S; Advincula J; Mayo MC; Natividad FF; Müller U
Arch Neurol; 2004 Dec; 61(12):1956-9. PubMed ID: 15596620
[TBL] [Abstract][Full Text] [Related]
15. Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism.
Makino S; Kaji R; Ando S; Tomizawa M; Yasuno K; Goto S; Matsumoto S; Tabuena MD; Maranon E; Dantes M; Lee LV; Ogasawara K; Tooyama I; Akatsu H; Nishimura M; Tamiya G
Am J Hum Genet; 2007 Mar; 80(3):393-406. PubMed ID: 17273961
[TBL] [Abstract][Full Text] [Related]
16. Understanding XDP through imaging, pathology, and genetics.
Pasco PM; Ison CV; Muňoz EL; Magpusao NS; Cheng AE; Tan KT; Lo RW; Teleg RA; Dantes MB; Borres R; Maranon E; Demaisip C; Reyes MV; Lee LV
Int J Neurosci; 2011; 121 Suppl 1():12-7. PubMed ID: 21034368
[TBL] [Abstract][Full Text] [Related]
17. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
Rosales RL; Ng AR; Santos MM; Fernandez HH
Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing.
Tshilenge KT; Bons J; Aguirre CG; Geronimo-Olvera C; Shah S; Rose J; Gerencser AA; Mak SK; Ehrlich ME; Bragg DC; Schilling B; Ellerby LM
Neurobiol Dis; 2024 Jan; 190():106367. PubMed ID: 38042508
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of pallidal deep brain stimulation in X-linked dystonia parkinsonism (XDP): Up to 84 months follow-up and review of literature.
Abejero JEE; Jamora RDG; Vesagas TS; Teleg RA; Rosales RL; Anlacan JP; Velasquez MS; Aguilar JA
Parkinsonism Relat Disord; 2019 Mar; 60():81-86. PubMed ID: 30262378
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
